WHO prequalifies new dengue vaccine

May 16, 2024 Media PBN Staff

New Delhi: The World Health Organization (WHO) prequalified a novel dengue vaccine on May 10, 2024. The vaccine TAK-003, is the second dengue vaccine to receive WHO prequalification.

It is a live-attenuated vaccine, created by Takeda, that contains weakened strains of the four serotypes of the dengue virus.

TAK-003 is recommended by the WHO for use in children aged 6 to 16 who live in areas with high dengue burden and intensity of transmission. The vaccination ought to be given in two doses separated by three months apart.

According to Dr. Rogerio Gaspar, WHO Director for Regulation and Prequalification, “the prequalification of TAK-003 is an important step in the expansion of global access to dengue vaccines, as it is now eligible for procurement by UN agencies including UNICEF and PAHO.”

Media PBN Staff

Media PBN Desk is a proactive digital news and content management wing, committed to providing accurate, timely and comprehensive updates on regional affairs. Keeping an eye on every news, big or small, this media desk acts as a strong link between the government and the public. It closely monitors and reports on state policies, administrative decisions, court proceedings and socio-political developments. Focusing on journalistic integrity and digital expertise, this team is an expert in transforming complex government and administrative news into simple, interesting and readable content. Using modern digital tools and a prompt reporting system, Mediapbn.com desk ensures that everything from court decisions to public interest news reaches the readers with complete clarity and speed. It is always ready to educate citizens through unbiased journalism.